Annual EBITDA
-$107.48 M
+$15.03 M+12.27%
December 1, 2024
Summary
- As of March 13, 2025, TNYA annual EBITDA is -$107.48 million, with the most recent change of +$15.03 million (+12.27%) on December 1, 2024.
- During the last 3 years, TNYA annual EBITDA has fallen by -$37.63 million (-53.88%).
- TNYA annual EBITDA is now -317.84% below its all-time high of -$25.72 million, reached on December 31, 2019.
Performance
TNYA EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$22.56 M
+$2.05 M+8.32%
December 1, 2024
Summary
- As of March 13, 2025, TNYA quarterly EBITDA is -$22.56 million, with the most recent change of +$2.05 million (+8.32%) on December 1, 2024.
- Over the past year, TNYA quarterly EBITDA has increased by +$6.70 million (+22.90%).
- TNYA quarterly EBITDA is now -173.09% below its all-time high of -$8.26 million, reached on June 1, 2020.
Performance
TNYA Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$107.48 M
+$6.70 M+5.87%
December 1, 2024
Summary
- As of March 13, 2025, TNYA TTM EBITDA is -$107.48 million, with the most recent change of +$6.70 million (+5.87%) on December 1, 2024.
- Over the past year, TNYA TTM EBITDA has increased by +$15.03 million (+12.27%).
- TNYA TTM EBITDA is now -1137.96% below its all-time high of -$8.68 million, reached on March 31, 2020.
Performance
TNYA TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
TNYA EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +12.3% | +22.9% | +12.3% |
| 3 y3 years | -53.9% | +21.5% | +14.5% |
| 5 y5 years | -317.8% | +21.5% | +14.5% |
TNYA EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -53.9% | +12.3% | at high | +31.4% | -53.9% | +14.8% |
| 5 y | 5-year | -317.8% | +12.3% | -173.1% | +31.4% | -1138.0% | +14.8% |
| alltime | all time | -317.8% | +12.3% | -173.1% | +31.4% | -1138.0% | +14.8% |
Tenaya Therapeutics EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$107.48 M(-12.3%) | -$22.56 M(-8.3%) | -$107.48 M(-5.9%) |
| Sep 2024 | - | -$24.61 M(-14.3%) | -$114.18 M(-3.5%) |
| Jun 2024 | - | -$28.70 M(-9.2%) | -$118.31 M(-3.4%) |
| Mar 2024 | - | -$31.61 M(+8.0%) | -$122.52 M(+0.0%) |
| Dec 2023 | -$122.51 M(+2.8%) | -$29.27 M(+1.8%) | -$122.51 M(-2.5%) |
| Sep 2023 | - | -$28.74 M(-12.7%) | -$125.67 M(-0.4%) |
| Jun 2023 | - | -$32.91 M(+4.2%) | -$126.15 M(+4.6%) |
| Mar 2023 | - | -$31.59 M(-2.6%) | -$120.56 M(+1.2%) |
| Dec 2022 | -$119.15 M | -$32.43 M(+11.0%) | -$119.15 M(+6.3%) |
| Sep 2022 | - | -$29.21 M(+6.9%) | -$112.09 M(+11.6%) |
| Jun 2022 | - | -$27.32 M(-9.5%) | -$100.44 M(+14.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$30.19 M(+19.0%) | -$87.62 M(+25.4%) |
| Dec 2021 | -$69.84 M(+91.7%) | -$25.37 M(+44.5%) | -$69.84 M(+29.0%) |
| Sep 2021 | - | -$17.55 M(+21.0%) | -$54.14 M(+16.7%) |
| Jun 2021 | - | -$14.50 M(+16.8%) | -$46.40 M(+15.5%) |
| Mar 2021 | - | -$12.42 M(+28.5%) | -$40.16 M(+10.3%) |
| Dec 2020 | -$36.43 M(+41.6%) | - | - |
| Dec 2020 | - | -$9.66 M(-1.6%) | -$36.43 M(+36.1%) |
| Sep 2020 | - | -$9.82 M(+18.9%) | -$26.77 M(+58.0%) |
| Jun 2020 | - | -$8.26 M(-4.8%) | -$16.94 M(+95.2%) |
| Mar 2020 | - | -$8.68 M | -$8.68 M |
| Dec 2019 | -$25.72 M | - | - |
FAQ
- What is Tenaya Therapeutics annual EBITDA?
- What is the all time high annual EBITDA for Tenaya Therapeutics?
- What is Tenaya Therapeutics annual EBITDA year-on-year change?
- What is Tenaya Therapeutics quarterly EBITDA?
- What is the all time high quarterly EBITDA for Tenaya Therapeutics?
- What is Tenaya Therapeutics quarterly EBITDA year-on-year change?
- What is Tenaya Therapeutics TTM EBITDA?
- What is the all time high TTM EBITDA for Tenaya Therapeutics?
- What is Tenaya Therapeutics TTM EBITDA year-on-year change?
What is Tenaya Therapeutics annual EBITDA?
The current annual EBITDA of TNYA is -$107.48 M
What is the all time high annual EBITDA for Tenaya Therapeutics?
Tenaya Therapeutics all-time high annual EBITDA is -$25.72 M
What is Tenaya Therapeutics annual EBITDA year-on-year change?
Over the past year, TNYA annual EBITDA has changed by +$15.03 M (+12.27%)
What is Tenaya Therapeutics quarterly EBITDA?
The current quarterly EBITDA of TNYA is -$22.56 M
What is the all time high quarterly EBITDA for Tenaya Therapeutics?
Tenaya Therapeutics all-time high quarterly EBITDA is -$8.26 M
What is Tenaya Therapeutics quarterly EBITDA year-on-year change?
Over the past year, TNYA quarterly EBITDA has changed by +$6.70 M (+22.90%)
What is Tenaya Therapeutics TTM EBITDA?
The current TTM EBITDA of TNYA is -$107.48 M
What is the all time high TTM EBITDA for Tenaya Therapeutics?
Tenaya Therapeutics all-time high TTM EBITDA is -$8.68 M
What is Tenaya Therapeutics TTM EBITDA year-on-year change?
Over the past year, TNYA TTM EBITDA has changed by +$15.03 M (+12.27%)